Cargando…
Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice
Our previous studies have implicated signaling through the tumor necrosis family receptors OX40 and CD30 as critical for maintaining CD4 memory responses. We show that signals through both molecules are also required for CD4 effector-mediated autoimmune tissue damage. Under normal circumstances, mal...
Autores principales: | M.Gaspal, Fabrina, Withers, David, Saini, Manoj, Bekiaris, Vasileios, McConnell, Fiona M., White, Andrea, Khan, Mahmood, Yagita, Hideo, Walker, Lucy S.K., Anderson, Graham, Lane, Peter J.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149223/ https://www.ncbi.nlm.nih.gov/pubmed/21788408 http://dx.doi.org/10.1084/jem.20101484 |
Ejemplares similares
-
Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity
por: Nawaf, Maher G., et al.
Publicado: (2017) -
Lymphoid Tissue Inducer Cells: Pivotal Cells in the Evolution of CD4 Immunity and Tolerance?
por: Lane, Peter J. L., et al.
Publicado: (2012) -
Critical Contribution of Ox40 Ligand to T Helper Cell Type 2 Differentiation in Experimental Leishmaniasis
por: Akiba, Hisaya, et al.
Publicado: (2000) -
Corrigendum: Evolving Strategies for Cancer and Autoimmunity: Back to the Future
por: Lane, Peter J. L., et al.
Publicado: (2014) -
Evolving Strategies for Cancer and Autoimmunity: Back to the Future
por: Lane, Peter J. L., et al.
Publicado: (2014)